CN Patent

CN110272419A — 二氢吡啶并酞嗪酮衍生物、其制备方法及应用

Assigned to Shanghai Allist Pharmaceuticals Inc · Expires 2019-09-24 · 7y expired

What this patent protects

本发明涉及下述通式(I)所示的二氢吡啶并酞嗪酮衍生物、其制备方法与应用，式中R 1 、R 2 、R 3 、m、n、环A和环B如说明书中所定义。本发明所述二氢吡啶并酞嗪酮衍生物具有良好的PARP抑制活性，可用于治疗或预防因抑制PARP活性而改善的疾病。

USPTO Abstract

本发明涉及下述通式(I)所示的二氢吡啶并酞嗪酮衍生物、其制备方法与应用，式中R 1 、R 2 、R 3 、m、n、环A和环B如说明书中所定义。本发明所述二氢吡啶并酞嗪酮衍生物具有良好的PARP抑制活性，可用于治疗或预防因抑制PARP活性而改善的疾病。

Drugs covered by this patent

Patent Metadata

Patent number
CN110272419A
Jurisdiction
CN
Classification
—
Expires
2019-09-24
Drug substance claim
No
Drug product claim
No
Assignee
Shanghai Allist Pharmaceuticals Inc
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.